
CPHI Milan 2026
10/2026 – 10/2026
WuXi Biologics is a leading contract research, development and manufacturing organization providing end-to-end capabilities to healthcare organizations worldwide. With operations in the United States, Ireland, Germany, Singapore and China, the company enables partners to effectively and efficiently bring biologics and vaccines to patients worldwide through its comprehensive, high-quality drug development model; WuXi XDC and WuXi Vaccines, two subsidiaries, offer end-to-end platforms for developing and manufacturing bioconjugates and vaccines, respectively.

No comments available.
Leave your rating & comment